Literature DB >> 19784448

Trends in tuberculosis incidence and their determinants in 134 countries.

C Dye1, K Lönnroth, E Jaramillo, B G Williams, M Raviglione.   

Abstract

OBJECTIVE: To determine whether differences in national trends in tuberculosis incidence are attributable to the variable success of control programmes or to biological, social and economic factors.
METHODS: We used trends in case notifications as a measure of trends in incidence in 134 countries, from 1997 to 2006, and used regression analysis to explore the associations between these trends and 32 measures covering various aspects of development (1), the economy (6), the population (3), behavioural and biological risk factors (9), health services (6) and tuberculosis (TB) control (7).
FINDINGS: The TB incidence rate changed annually within a range of +/-10% over the study period in the 134 countries examined, and its average value declined in 93 countries. The rate was declining more quickly in countries that had a higher human development index, lower child mortality and access to improved sanitation. General development measures were also dominant explanatory variables within regions, though correlation with TB incidence trends varied geographically. The TB incidence rate was falling more quickly in countries with greater health expenditure (situated in central and eastern Europe and the eastern Mediterranean), high-income countries with lower immigration, and countries with lower child mortality and HIV infection rates (located in Latin America and the Caribbean). The intensity of TB control varied widely, and a possible causal link with TB incidence was found only in Latin America and the Caribbean, where the rate of detection of smear-positive cases showed a negative correlation with national incidence trends.
CONCLUSION: Although TB control programmes have averted millions of deaths, their effects on transmission and incidence rates are not yet widely detectable.

Entities:  

Mesh:

Year:  2009        PMID: 19784448      PMCID: PMC2739916          DOI: 10.2471/blt.08.058453

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  21 in total

1.  Recent transmission of tuberculosis in Madrid: application of capture-recapture analysis to conventional and molecular epidemiology.

Authors:  J Iñigo; A Arce; J M Martín-Moreno; R Herruzo; E Palenque; F Chaves
Journal:  Int J Epidemiol       Date:  2003-10       Impact factor: 7.196

Review 2.  Targets for global tuberculosis control.

Authors:  C Dye; D Maher; D Weil; M Espinal; M Raviglione
Journal:  Int J Tuberc Lung Dis       Date:  2006-04       Impact factor: 2.373

3.  WHO's new Stop TB Strategy.

Authors:  Mario C Raviglione; Mukund W Uplekar
Journal:  Lancet       Date:  2006-03-18       Impact factor: 79.321

4.  Prospects for worldwide tuberculosis control under the WHO DOTS strategy. Directly observed short-course therapy.

Authors:  C Dye; G P Garnett; K Sleeman; B G Williams
Journal:  Lancet       Date:  1998-12-12       Impact factor: 79.321

5.  Evolution of tuberculosis control and prospects for reducing tuberculosis incidence, prevalence, and deaths globally.

Authors:  Christopher Dye; Catherine J Watt; Daniel M Bleed; S Mehran Hosseini; Mario C Raviglione
Journal:  JAMA       Date:  2005-06-08       Impact factor: 56.272

6.  The effect of tuberculosis control in China.

Authors: 
Journal:  Lancet       Date:  2004 Jul 31-Aug 6       Impact factor: 79.321

7.  Tuberculosis in New York City--turning the tide.

Authors:  T R Frieden; P I Fujiwara; R M Washko; M A Hamburg
Journal:  N Engl J Med       Date:  1995-07-27       Impact factor: 91.245

8.  Validation of the surveillance system for new cases of tuberculosis in a province of northern Italy. Varese Tuberculosis Study Group.

Authors:  G B Migliori; A Spanevello; L Ballardini; M Neri; C Gambarini; M L Moro; L Trnka; M C Raviglione
Journal:  Eur Respir J       Date:  1995-08       Impact factor: 16.671

Review 9.  New measurable indicator for tuberculosis case detection.

Authors:  Martien W Borgdorff
Journal:  Emerg Infect Dis       Date:  2004-09       Impact factor: 6.883

10.  Assessing household solid fuel use: multiple implications for the Millennium Development Goals.

Authors:  Eva Rehfuess; Sumi Mehta; Annette Prüss-Ustün
Journal:  Environ Health Perspect       Date:  2006-03       Impact factor: 9.031

View more
  105 in total

1.  Rv1218c, an ABC transporter of Mycobacterium tuberculosis with implications in drug discovery.

Authors:  Meenakshi Balganesh; Sanjana Kuruppath; Nimi Marcel; Sreevalli Sharma; Anju Nair; Umender Sharma
Journal:  Antimicrob Agents Chemother       Date:  2010-10-04       Impact factor: 5.191

2.  Aerosolized gentamicin reduces the burden of tuberculosis in a murine model.

Authors:  Chad J Roy; Satheesh K Sivasubramani; Noton K Dutta; Smriti Mehra; Nadia A Golden; Stephanie Killeen; James D Talton; Badre E Hammoud; Peter J Didier; Deepak Kaushal
Journal:  Antimicrob Agents Chemother       Date:  2011-12-05       Impact factor: 5.191

3.  Vaccination of guinea pigs using mce operon mutants of Mycobacterium tuberculosis.

Authors:  Andrés Obregón-Henao; Crystal Shanley; María Verónica Bianco; Angel A Cataldi; Randall J Basaraba; Ian M Orme; Fabiana Bigi
Journal:  Vaccine       Date:  2011-04-22       Impact factor: 3.641

4.  A worldwide investigation of tuberculosis epidemics.

Authors:  Christine S M Currie; Kathryn A Hoad
Journal:  Health Care Manag Sci       Date:  2011-11-15

5.  Mycobacterium tuberculosis persistence mutants identified by screening in isoniazid-treated mice.

Authors:  Neeraj Dhar; John D McKinney
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-21       Impact factor: 11.205

6.  The challenge of sustaining effectiveness over time: the case of the global network to stop tuberculosis.

Authors:  Kathryn Quissell; Gill Walt
Journal:  Health Policy Plan       Date:  2015-08-17       Impact factor: 3.344

7.  Effect of Brazil's conditional cash transfer programme on tuberculosis incidence.

Authors:  J S Nery; L C Rodrigues; D Rasella; R Aquino; D Barreira; A W Torrens; D Boccia; G O Penna; M L F Penna; M L Barreto; S M Pereira
Journal:  Int J Tuberc Lung Dis       Date:  2017-07-01       Impact factor: 2.373

8.  Efflux pumps of Mycobacterium tuberculosis play a significant role in antituberculosis activity of potential drug candidates.

Authors:  Meenakshi Balganesh; Neela Dinesh; Sreevalli Sharma; Sanjana Kuruppath; Anju V Nair; Umender Sharma
Journal:  Antimicrob Agents Chemother       Date:  2012-02-06       Impact factor: 5.191

9.  Risks for tuberculosis in Kazakhstan: implications for prevention.

Authors:  A Davis; A Terlikbayeva; A Aifah; S Hermosilla; Z Zhumadilov; E Berikova; S Rakhimova; S Primbetova; M Darisheva; N Schluger; N El-Bassel
Journal:  Int J Tuberc Lung Dis       Date:  2017-01-01       Impact factor: 2.373

10.  Mycobacterium bovis BCG-mediated protection against W-Beijing strains of Mycobacterium tuberculosis is diminished concomitant with the emergence of regulatory T cells.

Authors:  Diane J Ordway; Shaobin Shang; Marcela Henao-Tamayo; Andres Obregon-Henao; Laura Nold; Megan Caraway; Crystal A Shanley; Randall J Basaraba; Colleen G Duncan; Ian M Orme
Journal:  Clin Vaccine Immunol       Date:  2011-07-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.